Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 246

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing

Tostões, Rui M., Leite, Sofia B., Serra, Margarida, Jensen, Janne, Björquist, Petter, Carrondo, Manuel J. T., Brito, Catarina, Alves, Paula M. · 2012 · Hepatology

Abstract

Primary cultures of human hepatocyte spheroids are a promising in vitro model for long-term studies of hepatic metabolism and cytotoxicity. The lack of robust methodologies to culture cell spheroids, as well as a poor characterization of human hepatocyte spheroid architecture and liver-specific functionality, have hampered a widespread adoption of this three-dimensional culture format. In this work, an automated perfusion bioreactor was used to obtain and maintain human hepatocyte spheroids. These spheroids were cultured for 3–4 weeks in serum-free conditions, sustaining their phase I enzyme expression and permitting repeated induction during long culture times; rate of albumin and urea synthesis, as well as phase I and II drug-metabolizing enzyme gene expression and activity of spheroid hepatocyte cultures, presented reproducible profiles, despite basal interdonor variability (n = 3 donors). Immunofluorescence microscopy of human hepatocyte spheroids after 3–4 weeks of long-term culture confirmed the presence of the liver-specific markers, hepatocyte nuclear factor 4α, albumin, cytokeratin 18, and cytochrome P450 3A. Moreover, immunostaining of the atypical protein kinase C apical marker, as well as the excretion of a fluorescent dye, evidenced that these spheroids spontaneously assemble a functional bile canaliculi network, extending from the surface to the interior of the spheroids, after 3–4 weeks of culture. Conclusion: Perfusion bioreactor cultures of primary human hepatocyte spheroids maintain a liver-specific activity and architecture and are thus suitable for drug testing in a long-term, repeated-dose format. (Hepatology 2012)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.24760

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 25

  1. GomezLechon, 2003, Human hepatocytes as a tool for studying toxicity and drug metabolism., Curr Drug Metab, 4, 292, 10.2174/1389200033489424 · DOI · Paper page
  2. Miranda, 2009, Towards an extended functional hepatocyte in vitro culture., Tissue Eng Part C Methods, 15, 157, 10.1089/ten.tec.2008.0352 · DOI
  3. Wu, 1999, Enhanced cytochrome P450 IA1 activity of selfassembled rat hepatocyte spheroids., Cell Transplant, 8, 233, 10.1177/096368979900800304 · DOI
  4. AbuAbsi, 2002, Structural polarity and functional bile canaliculi in rat hepatocyte spheroids., Exp Cell Res, 274, 56, 10.1006/excr.2001.5467 · DOI · Paper page
  5. DvirGinzberg, 2004, Ultrastructural and functional investigations of adult hepatocyte spheroids during in vitro cultivation., Tissue Eng, 10, 1806, 10.1089/ten.2004.10.1806 · DOI
  6. Goral, 2010, Perfusionbased microfluidic device for threedimensional dynamic primary human hepatocyte cell culture in the absence of biological or synthetic matrices or coagulants., Lab Chip, 10, 3380, 10.1039/c0lc00135j · DOI
  7. Nishimura, 2010, Secretion of albumin and Induction of CYP1A2 and CYP3A4 in novel threedimensional culture system for human hepatocytes using microspace plate., Drug Metab Pharmacokinet, 25, 236, 10.2133/dmpk.25.236 · DOI
  8. Domansky, 2010, Perfused multiwell plate for 3D liver tissue engineering., Lab Chip, 10, 51, 10.1039/B913221J · DOI · Paper page
  9. Khetani, 2008, Microscale culture of human liver cells for drug development., Nat Biotechnol, 26, 120, 10.1038/nbt1361 · DOI · Paper page
  10. Carpentier, 2009, Artificial and bioartificial liver devices: present and future., Gut, 58, 1690, 10.1136/gut.2008.175380 · DOI · Paper page
  11. Zeilinger, 2011, Scaling down of a clinical 3D perfusion multicompartment hollow fiber liver bioreactor developed for extracorporeal liver support to an analytical scale device useful for hepatic pharmacological in vitro studies., Tissue Eng Part C Methods, 17, 549, 10.1089/ten.tec.2010.0580 · DOI
  12. LeCluyse, 2001, Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation., Eur J Pharmaceut Sci, 13, 343, 10.1016/S0928-0987(01)00135-X · DOI · Paper page
  13. Curcio, 2007, Mass transfer and metabolic reactions in hepatocyte spheroids cultured in rotating wall gaspermeable membrane system., Biomaterials, 28, 5487, 10.1016/j.biomaterials.2007.08.033 · DOI · Paper page
  14. Waxman, 2006, Use of 7ethoxycoumarin to monitor multiple enzymes in the human CYP1, CYP2, and CYP3 families., Methods Mol Biol, 320, 153
  15. Dunn, 1991, Longterm in vitro function of adult hepatocytes in a collagen sandwich configuration., Biotechnol Prog, 7, 237, 10.1021/bp00009a007 · DOI · Paper page
  16. Wu, 1996, Efficient assembly of rat hepatocyte spheroids for tissue engineering applications., Biotechnol Bioeng, 50, 404, 10.1002/(SICI)1097-0290(19960520)50:4<404::AID-BIT7>3.0.CO;2-P · doi:10.1002/(sici)1097-0290(19960520)50:4<404::aid-bit7>3.0.co;2-p
  17. Foy, 1994, A device to measure the oxygenuptake rate of attached cells: importance in bioartificial organ design., Cell Transplant, 3, 515, 10.1177/096368979400300609 · DOI
  18. Leite, 2011, Merging bioreactor technology with 3D hepatocytefibroblast culturing approaches: improved in vitro models for toxicological applications., Toxicol In Vitro, 25, 825, 10.1016/j.tiv.2011.02.002 · DOI
  19. Kidambi, 2009, Oxygenmediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance., Proc Natl Acad Sci U S A, 106, 15714, 10.1073/pnas.0906820106 · DOI · Paper page
  20. Jungermann, 1997, Role of oxygen in the zonation of carbohydrate metabolism and gene expression in liver., Kidney Int, 51, 402, 10.1038/ki.1997.53 · DOI
  21. Brophy, 2009, Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function., HEPATOLOGY, 49, 578, 10.1002/hep.22674 · DOI
  22. Khaoustov, 1999, Induction of threedimensional assembly of human liver cells by simulated microgravity., In Vitro Cell Dev Biol Anim, 35, 501, 10.1007/s11626-999-0060-2 · DOI
  23. Ponsoda, 2001, Drug biotransformation by human hepatocytes. In vitroin vivo metabolism by cells from the same donor., J Hepatol, 34, 19, 10.1016/S0168-8278(00)00085-4 · DOI
  24. Schmelzer, 2009, Effect of human patient plasma ex vivo treatment on gene expression and progenitor cell activation of primary human liver cells in multicompartment 3D perfusion bioreactors for extracorporeal liver support., Biotechnol Bioeng, 103, 817, 10.1002/bit.22283 · DOI
  25. Katz, 1992, Metabolic heterogeneity of hepatocytes across the liver acinus., J Nutr, 122, 843, 10.1093/jn/122.suppl_3.843 · DOI

Cited by

See all 246

Metadata

Authors
Tostões, R. M., Leite, S. B., Serra, M., Jensen, J., Björquist, P., Carrondo, M. J. T., Brito, C., & Alves, P. M.
Venue
Hepatology
Published
2012-04
Volume
55
Issue
4
Pages
1227-1236
ISSN
0270-9139 (ISSN-L)
OpenAlex
W1980080300
Cited by
246
References
2
FWCI
8.97
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1248 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing. https://app.cochat.ai/papers/10.1002/hep.24760
The paper
Tostões, R. M., Leite, S. B., Serra, M., Jensen, J., Björquist, P., Carrondo, M. J. T., Brito, C., & Alves, P. M. (2012). Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing. Hepatology. https://doi.org/10.1002/hep.24760

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.